Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (10462)	2/17/2004 11:47:20 AM
From: rkrw	Respond to of 52153

Peter, Didn't know it had to be a secret. Firstly, I'm partially hedged, second, my price est was for within one week post decision. I think the upside over the course of the year could be much higher if they get a favorable decision and factor in an MDI nda filing due within 1-2 months. I'm not expecting a disastrous stock like the aftermath of the soltara rejection. Debt isn't as worrisome, xopenex sales, margins and the MDI can justify a solid base to the stock. I think $40+ this year is possible with approval and I think sepr will close the year at $20+ even without estorra approval. So as a binary 2/29 investment, yes I should sell now, but with a LT view, I think the scales will tilt toward holding. And then you have tax implications :-) And this might be a good time to recount sepr prior to its last pdufa date: Closing price 3/6/02: $47.27 (actually went up $3 that day in anticipation!) Closing price 3/7/02: $19.64 Post Rej peak: 3/19: $22.25 Single Digits: 6/2: $9.93 Bottom: 9/24/02: $3.90 Jim